16:41 EDT Solid Biosciences (SLDB) files $400M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLDB:
- Solid Biosciences Advances Gene Therapy Pipeline
- Solid Biosciences reports inducement grants under Nasdaq listing rule
- Climb Bio appoints Kim Cobleigh Drapkin, Bo Cumbo to board
- Vaccine, gene therapy makers fall after Peter Marks resignation
- Moderna (NASDAQ:MRNA) Leads U.S. Biotechs’ Plunge after FDA’s Top Vaccine Regulator Resigns